Both Eli Lilly LLY and Merck MRK are major players in the U.S. pharmaceutical industry, developing and commercializing therapies across oncology, immunology, and diabetes and cardiovascular areas.

President Donald Trump said he asked major pharmaceutical companies to take steps to cut U.S. drug prices within the next 60 ...

President Trump urges top pharmaceutical firms to lower U.S. drug prices under his most-favored-nation drug pricing policy ...

SINGAPORE (Reuters) -Shares of European drugmakers slipped on Friday after U.S. President Donald Trump sent letters to major ...

In letters posted on Truth Social, Trump demanded that drugmakers offer their medications at the same prices paid abroad.

President Donald Trump is ratcheting up the pressure on major drugmakers to bring their US prices in line with the far lower ...

Merck KGaA is spending $85 million to get global commercialization rights to pimicotinib, a candidate for non-malignant tumors that it licensed from Abbisko Therapeutics. Eli Lilly is expanding its ...

In 17 identical letters posted to his Truth Social account, the president said companies must lower their prices or the ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

An obesity drug from Hengrui Pharma and Kailera Therapeutics succeeded in a late-stage trial in China, while Anne Wojcicki’s ...

Though specifics of the order were not clear, shares of all large drugmakers, J&J, Eli Lilly, Pfizer, Merck, Gilead, Bristol-Myers, Amgen and several other U.S. pharmaceutical stocks were on the ...